Over the weekend, news broke that Merus N.V. $MRUS is being acquired by Genmab $GMAB for $97 per share. The stock closed Friday at $69, sitting at the upper end of a more than two-month sideways consolidation.

We were in it.

Back on June...

Sometimes a trade works out exactly as planned. This was one of those times.

Back on July 30th, I entered a position in Junior Gold Miners $GDXJ, thanks to excellent research from Jason Perz and Sam Gatlin at the...

The best part about the end of the month is digging into a fresh batch of monthly charts.

“Whenever in doubt, zoom out” — that’s something I’ve learned from JC over the years.

Monthly charts make it impossible to ignore the bigger picture...

Speculative growth is back in the driver’s seat with the flagship ARK fund kicking off the week with fresh cycle highs on both absolute and relative terms.

We’ve been leaning back into this theme since early September, and...

One of the clearest ways to gauge market risk appetite is by tracking where investors are putting their money.

For me, the best way to do this is by comparing Consumer Discretionary to Consumer Staples.

Discretionary stocks represent...

Welcome back for another Top Down Trade of the Week.

This is a classic leadership scan.

We start with the best sectors, then drill into the subgroups. We pick one, and then take a look at the top stocks...

Have you ever felt like there's a glass ceiling on your profitability?

That no matter how hard you try, you cannot make more than X amount of dollars on any one trading day, week, month, or year?

Do you fill with dread whenever you're...

Today was one of those days that reminded me why diversification matters.

My...